Recent progress of benzimidazole and Indole derivatives as anticancer

In present situation cancer became a cruel reality to human lives due to their resistance to accessible drugs. Thus, discovery of new types of anticancer drugs becomes very critical.Heterocyclic entities act as medications since they have precise synthetic reactivity and they give advantageous site to which bioactive substituents can be bind. Subsequently, there is need for the improvement of pharmacologically active heterocycles in synthetic and therapeutic science with certain focal points including its effortlessness of activity, greener methodology, simple workup strategy, selectivity, higher yields and high-particleMonetary.The role of Benzimidazole and Isoindole derivatives in drug design and synthesis of pharmacologically important molecules has grown enormously worldwide.Benzimidazole and Isoindole derivatives have received attention due to their remarkable biological activities. These scaffolds have been consistently rewarded as a promising versatile lead molecule with a pivotal position in modern medicinal chemistry.A major aim of this book was to provide recent anticancer activity of Benzimidazole and Isoindole

Autorentext

O Dr. Rakesh Kumar trabalha como Professor Assistente no Departamento de Engenharia Eletrónica e de Comunicações na I.K. Gujral Punjab Technical University, Main Campus, Kapurthala, Punjab, Índia. Tem uma experiência total de ensino e investigação de 22 anos. As suas áreas de especialização são Algoritmos Genéticos, Redes Móveis Ad-hoc e Internet das Coisas (IoT).